UCO.investment.consulting@gmail.com
1-778-584-9615

Big US banks to face Fed's annual stress tests this week

Addtime:2023-06-26 Click: 130

Big U.S. lenders will see if they made the grade this week as the Federal Reserve reports the results of its annual "stress tests."

Despite this past Spring's turmoil in the sector, the institutions are expected to show they have ample capital to weather any fresh trouble.

Although investor payouts are likely to dip slightly, analysts said.

The central bank on Wednesday will release the results of its bank health checks which assess how much capital banks would need to withstand a severe economic downturn.

Bank logos

Big U.S. lenders will see if they made the grade this week as the Federal Reserve reports the results of its annual "stress tests." (REUTERS/File Photo)

The results help decide a banks' capital planning, dictating how much cash they can return to shareholders via dividends and share buybacks.

The Fed instituted the annual exercise following the 2007-2009 financial crisis.

TickerSecurityLastChangeChange %
CCITIGROUP INC.46.03-0.60-1.29%
BACBANK OF AMERICA CORP.27.76-0.19-0.68%
JPMJPMORGAN CHASE & CO.138.82-0.76-0.54%

This year's tests come after the recent banking crisis in which Silicon Valley Bank and two other lenders failed. 

Federal Reserve Building

The central bank will release the results of its bank health checks on Wednesday, which assesses how much capital banks would need to withstand a severe economic downturn.

Wall Street lenders including Citigroup Inc, Bank of America , JPMorgan Chase, Goldman Sachs Group, Wells Fargo, and Morgan Stanley usually attract the most attention. 

Also in focus will be smaller lenders including Capital One, U.S. Bancorp, and Citizens.

TickerSecurityLastChangeChange %
GSTHE GOLDMAN SACHS GROUP INC.314.71-4.88-1.53%
MSMORGAN STANLEY83.58-0.92-1.09%
WFCWELLS FARGO & CO.40.60-0.45-1.10%

Banks will be scrutinized a little tougher this year, but analysts and executives expect the 23 lenders being tested will show capital in excess of regulatory minimums.